Could CVS Make a Copy of Ozempic?
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
On Aug. 23, CVS Health (NYSE: CVS) made waves when it announced that it will be launching a new business called Cordavis that will be devoted to commercializing biosimilar medicines. If you aren’t familiar, biosimilars are generic versions of biologic drugs, which tend to be newe
:max_bytes(150000):strip_icc():format(jpeg)/paperwork-4596472be17e44b691fc63ab4caa74a4.jpg "<div>Taxable Income vs. Gross Income: What's the Difference?</div>")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1438233969-08b4f322bd6f4c04b75978968d305bd5.jpg "How Is Your 401(k) Taxed in Retirement?")